DigestRedComo funciona
Red
/
Empresas
Ga
No verificado

Galderma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

60 Comunicados de prensa

Ver todos los comunicados de prensa
21/09/2026
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies
Fuente
Galderma
Editor
Business Wire
1.00
0
16/09/2026
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing
Fuente
Galderma
Editor
Business Wire
1.00
0
11/08/2026
Multimedia
Industria
Biotecnología
Farmacéutica
Salud
Sanidad
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
Fuente
Galderma
Editor
Business Wire
1.00
0
20/07/2026
Biotecnología
Farmacéutica
Salud
Sanidad
Industria
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
Fuente
Galderma
Editor
Business Wire
1.00
0
07/07/2026
Multimedia
Salud
Sanidad
Ciencia
Biotecnología
Análisis de Mercados
Industria
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
Fuente
Galderma
Editor
Business Wire
1.00
0
11/06/2026
Multimedia
Análisis de Mercados
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
Fuente
Galderma
Editor
Business Wire
1.00
0
22/05/2026
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
Fuente
Galderma
Editor
Business Wire
1.00
0
16/04/2026
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
Fuente
Galderma
Editor
Business Wire
1.00
0
09/04/2026
Industria
Salud
Ir de compras
Fitness
Medicina - Varios
Farmacéutica
Biotecnología
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
Fuente
Galderma
Editor
Business Wire
1.00
0
07/04/2026
Industria
Biotecnología
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Debuts ALASTIN Signature Practices in Partnership With Leading Aesthetic Practices to Elevate Regenerative, Peri-Procedural Skincare
Fuente
Galderma
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0